S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

SLN Silence Therapeutics PLC

22.19

0.29 (1.32%)

After Hours

Last Updated: 08:20:29

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Silence Therapeutics (NASDAQ:SLN)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Silence Therapeutics Charts.

Silence Therapeutics (NASDAQ:SLN)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Silence Therapeutics Charts.

Silence Therapeutics PLC News

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Tuesday 30 April 2024 (1 week ago) • Business Wire

Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
Monday 29 April 2024 (1 week ago) • Business Wire

Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
Tuesday 9 April 2024 (4 weeks ago) • Business Wire

Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
Wednesday 13 March 2024 (2 months ago) • Business Wire

Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb
Wednesday 13 March 2024 (2 months ago) • IH Market News

Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
Wednesday 13 March 2024 (2 months ago) • Business Wire

Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
Thursday 29 February 2024 (2 months ago) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)

Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
Saturday 24 February 2024 (2 months ago) • Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
Tuesday 6 February 2024 (3 months ago) • Business Wire

More Silence Therapeutics PLC News Articles

Commonwealth Bank Of Aus...

Australia And New Zealan...

Gold vs US Dollar

Verizon Communications

Woodside Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions